Accuryn Medical

Executive Summary

Accuryn Medical (operating as Potrero Medical) is a San Diego-based predictive health company focused on transforming critical care through its Accuryn Monitoring System. This system upgrades a standard Foley catheter into a smart, AI-powered device capable of real-time automated monitoring, enabling early detection and prediction of acute kidney injury (AKI). Founded in 2012, the company has developed a novel sensor platform that continuously tracks key physiological parameters, potentially reducing AKI incidence by alerting clinicians hours before traditional lab results. With a strong intellectual property portfolio and a clear regulatory pathway, Accuryn addresses a massive unmet need in intensive care, where AKI affects up to 50% of patients. The company targets a multi-billion dollar market and has the potential to become a standard of care in critical care monitoring.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for Accuryn System v2.080% success
• Q4 2026Publication of pivotal clinical trial results70% success
• Q2 2026Strategic partnership with major hospital network60% success